This trial showed similar aneurysm growth in both treatment and control groups, but was undoubtedly underpowered to test any conceivable effect and therefore the effect of IL-1β neutralization on AAA growth remains unclear [86]. This evidence concerns the gene IL1B and triple-A syndrome.